GENE ONLINE|News &
Opinion
Blog

BioNTech
New COVID-19 Variant: Vaccine Makers Optimistic but Experts are Cautious over Unique Mutations
2020-12-24
Fosun to Import 100 Million Doses of BioNTech’s COVID-19 Vaccine into China
2020-12-17
Singapore Becomes First Country in Asia Pacific to Greenlight Pfizer/BioNTech’s COVID-19 Vaccine
2020-12-16
FDA Green Lights Very First COVID-19 Vaccine in the US
2020-12-12
Pfizer’s COVID Vaccine Inches Closer to Emergency Approval Following FDA Panel’s Recommendation
2020-12-11
COVID-19: BioNTech Commences Phase 2 Vaccine Trials in China with Fosun
2020-12-05
Final Analysis Suggests Pfizer, BioNTech’s COVID-19 Vaccine is Safe with 95% Efficacy
2020-11-18
How Does Moderna’s mRNA Vaccine Measure Up to Pfizer’s?
2020-11-16
Interim Analysis Shows Pfizer & BioNTech’s COVID-19 Vaccine is 90% Effective
2020-11-09
COVID-19: CureVac Announces Promising Phase 1 Results with Lower Vaccine Dosage Than Competitors
2020-11-03
Taiwan’s TTY Biopharm Company Signs COVID-19 Vaccine Deal with BioNTech for 30 Million Doses
2020-10-20
Recent Updates on COVID-19 Vaccines Development
2020-09-15
BioNTech to Test mRNA-Based Cancer Vaccine with Regeneron’s anti-PD1 Drug in Melanoma Patients
2020-08-04
Pfizer & BioNTech’s COVID-19 Vaccine Receives FDA’s Fast Track Designation
2020-07-15
Pfizer and BioNTech’s COVID-19 Vaccine Shows Encouraging Results
2020-07-05
1 2 3
LATEST
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
EVENT
Scroll to Top